Clinical Trial Update: Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of GOCOVRI (amantadine, extended release) on gait in Parkinson disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Gocovri (amantadine extended-release)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-10-10